Valuation: Abbott India Limited

Market Cap 558B 5.86B 5.26B 4.85B 4.4B 8.21B 8.32B 58.09B 23.14B 292B 22B 21.54B 926B P/E 2027 *
32.4x
P/E 2028 * 29.2x
Enterprise Value 535B 5.61B 5.03B 4.65B 4.22B 7.86B 7.97B 55.61B 22.15B 280B 21.06B 20.62B 886B EV / Sales 2027 *
7.14x
EV / Sales 2028 * 6.48x
Free-Float
24.46%
Yield 2027 *
2.57%
Yield 2028 * 2.69%
1 day+3.10%
1 week+1.70%
Current month-3.21%
1 month-2.44%
3 months-5.52%
6 months+3.25%
Current year-9.60%
1 week 24,670.1
Extreme 24670.1
26,444.6
1 month 24,670.1
Extreme 24670.1
27,845
Current year 24,670.1
Extreme 24670.1
29,250
1 year 24,670.1
Extreme 24670.1
30,598
3 years 21,983.4
Extreme 21983.4
35,921.55
5 years 15,525
Extreme 15525
35,921.55
10 years 3,996
Extreme 3996
35,921.55
Manager TitleAgeSince
Chief Executive Officer 46 2025-06-13
Director of Finance/CFO 53 2025-05-05
Director of Finance/CFO - 2025-03-31
Director TitleAgeSince
Director/Board Member 69 2011-02-28
Chairman 71 2026-08-12
Director/Board Member 61 2019-10-28
Change 5-day change 1-year change 3-year change Capi.($)
+3.10%+1.70%-11.76%+16.09% 5.7B
+0.50%+0.36%+55.89%+129.96% 1,143B
+0.86%+4.50%+42.43%+86.15% 647B
-0.14%-1.07%+25.42%+105.85% 506B
-0.05%+2.28%+49.14%+67.74% 384B
-0.63%-4.97%+60.15%+37.06% 350B
+0.34%+2.15%+25.26%+54.27% 293B
-0.45%+1.16%+1.74%+26.08% 265B
+0.87%+2.94%+55.18%+72.74% 242B
+0.08%+1.72%+32.15%+107.78% 197B
Average +0.60%+0.62%+33.56%+70.37% 403.32B
Weighted average by Cap. +0.46%+0.70%+42.55%+88.91%

Financials

2027 *2028 *
Net sales 74.9B 787M 705M 651M 591M 1.1B 1.12B 7.79B 3.1B 39.2B 2.95B 2.89B 124B 82.04B 862M 773M 713M 647M 1.21B 1.22B 8.53B 3.4B 42.93B 3.23B 3.16B 136B
Net income 17.22B 181M 162M 150M 136M 253M 257M 1.79B 714M 9.01B 679M 664M 28.56B 19.08B 200M 180M 166M 150M 280M 284M 1.98B 791M 9.98B 752M 736M 31.64B
Net Debt -23.88B -251M -225M -208M -188M -351M -356M -2.48B -990M -12.5B -941M -921M -39.61B -26.98B -283M -254M -235M -213M -397M -402M -2.81B -1.12B -14.12B -1.06B -1.04B -44.75B
Projected Income Statement - Annual - Abbott India Limited
Logo Abbott India Limited
Abbott India Limited is an India-based pharmaceutical company. The Company is involved in product development, manufacturing, sales, and customer service. It distributes products and solutions in multiple therapeutic categories, such as women's health, gastroenterology, cardiology, metabolic disorders and primary care. It operates in a single reportable business segment, which is Pharmaceuticals. The Company’s products include Arachitol Nano, Digeraft, Influvac, Colospa, Duphalac, Librax, Creon, Duphaston, Prothiaden, Cremaffin, Duvadilan, Thyronorm, Cremaffin Plus, Ganaton, Udiliv, Digene, Heptral, Vertin, Zolfresh, Citrosoda UTI, Digene Insta On The Go, Digeraft tablet, Duphaston OD, Pneumoshield 14, Prothiaden Neu, Vonefi, Levesam, and LOBATE M Skin Cream, among others. The Company sells its products through independent distributors primarily within India.
Employees
3,679
Date Price Change Volume
26-10-28 ₹26,278.90 +3.10% 434
26-10-27 ₹25,488.50 +1.06% 167
26-10-26 ₹25,222.05 +0.87% 4,464
26-10-23 ₹25,004.30 -1.53% 4,518
26-10-22 ₹25,393.50 -1.36% 363
Trader
Investor
Global
-
Quality
ESG MSCI
-
MarketScreener Ratings - Abbott India Limited

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Abbott India Limited
  1. Stock Market
  2. Stocks
  3. ABBOTINDIA Stock